Broadleaf Partners, LLC Abbott Laboratories Transaction History
Broadleaf Partners, LLC
- $411 Million
- Q3 2024
A detailed history of Broadleaf Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Broadleaf Partners, LLC holds 5,811 shares of ABT stock, worth $716,031. This represents 0.16% of its overall portfolio holdings.
Number of Shares
5,811
Previous 5,811
-0.0%
Holding current value
$716,031
Previous $603,000
9.78%
% of portfolio
0.16%
Previous 0.15%
Shares
8 transactions
Others Institutions Holding ABT
# of Institutions
3,204Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$20.7 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.45 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.1 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.57 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $216B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...